Olympus Debuts ENT, Urological Imaging Platform in U.S.

Olympus began the U.S. launch of the Visera S OTV-S500 imaging platform, which integrates advanced diagnostic capabilities for ear, nose, and throat (ENT) and urology applications and provides flexibility for office and outpatient settings.

The Visera S video system touts a built-in light system that lets clinicians switch between white light, stroboscopy mode available via strobe upgrade, and Narrow Band Imaging (NBI) tech at one button’s touch. This allows enhanced visualization to detect, characterize, and treat ENT diseases like vocal fold polyps and glottic cancer and urological diseases like non-muscle invasive bladder cancer.

The video system integrates with Olympus’ nCare medical recorder and VaultStream medical content management system platform. This lets physicians capture clear recordings and create a comprehensive procedural record that can be accessed and shared from different sites in a medical facility.

Stroboscopy light

The Visera S system offers broad compatibility with flexible and rigid endoscopes, including diagnostic and therapeutic video rhinolaryngoscopes.

The built-in stroboscopy mode is activated with a software upgrade available via a portable memory port. A stroboscopy exam lets an ENT specialist examine the mucosa around the vocal cords and spot small changes in vibration when there are diagnostic doubts surrounding vocal core lesions.

Urology and NBI technology

Visera S is compatible with HD camera leads, flexible ureteroscopes, and FD flexible cysto-nephro videoscopes.

The video system is designed for improved color, resolution, and depth of field to offer a clear view of fine vascular structures. NBI technology comes standard on the new imaging platform, and is shown to lead to 37% less likelihood of non-muscle invasive bladder cancer recurrence over 12-35 months. NBI technology is not intended to replace histopathological sampling as a means of diagnosis.

“Whether in an office or outpatient setting, physicians are looking for opportunities to combine procedural and cost efficiencies, which is why we are excited to launch the VISERA S imaging platform for ENT and urological applications,” said Richard Reynolds, President of the Medical Systems Group at Olympus Corporation of the Americas. “The VISERA S video system may provide cost efficiencies by offering compatibility with a wide range of endoscopes and procedural and workflow efficiencies by combining multiple light systems in one platform and the ability to gather and share patient data from one system.”

Earlier this summer, the company and Revival Healthcare Capital (Revival) became founding partners in Swan EndoSurgical, a new company that developing gastrointestinal robotics technology.